Detection of serum sICAM-1 in patients with malignant ovarian tumor and its clinical value
Huiling Pei
Abstract
Huiling Pei
Abstract
Objective To investigate soluble intercellular adhesion molecule-1(sICAM-1) and analyse its clinical value.Methods Double antibody sandwich ELISA method was applied to examine serum sICAM-1 in 54 patients with malignant ovarian tumor while the relationship between sICAM-1 and the clinical stages was studied.Results The concentrations of serum sICAM-1 in 54 cases with malignant ovarian tumors were higher obviously than the control group(P0.01),the serum sICAM- 1 with malignant ovavian tumors at late stages(Ⅲ~Ⅳ) was higher obviously than that at early stages (Ⅰ~Ⅱ)(P0.05).Conclusion Serum sICAM-1 may be used as a marker for monitoring the prog- nosis of ovarian carcinomae.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate soluble intercellular adhesion molecule-1(sICAM-1) and analyse its clinical value.Methods Double antibody sandwich ELISA method was applied to examine serum sICAM-1 in 54 patients with malignant ovarian tumor while the relationship between sICAM-1 and the clinical stages was studied.Results The concentrations of serum sICAM-1 in 54 cases with malignant ovarian tumors were higher obviously than the control group(P0.01),the serum sICAM- 1 with malignant ovavian tumors at late stages(Ⅲ~Ⅳ) was higher obviously than that at early stages (Ⅰ~Ⅱ)(P0.05).Conclusion Serum sICAM-1 may be used as a marker for monitoring the prog- nosis of ovarian carcinomae.
Key concepts: Ovarian cancer, Medicine, Ovarian tumor, Internal medicine, Serum concentration, Antibody, Gastroenterology, Pathology